Adrenalectomy modifies the hippocampal 5-HT1A receptors and the anxiolytic-like effect of 8-OH-DPAT in rats

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 1, 2009, Pages 182-189

  Briones Aranda, Alfredo ^a   Castillo Salazar, Mariano ^b   Picazo, Ofir ^b  

^a UNIVERSIDAD AUTÓNOMA DE CHIAPAS   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

5 HT1A; Adrenalectomy; Anxiety; Hippocampus; Rats; Stress

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 SUCCINIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; LIGAND; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ADRENAL GLAND; ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DENSITY; DORSAL RAPHE NUCLEUS; DRUG EFFECT; FORCED SWIMMING TEST; HIPPOCAMPUS; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; STRESS; TRANQUILIZING ACTIVITY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENALECTOMY; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; AUTORADIOGRAPHY; HIPPOCAMPUS; MALE; MOTOR ACTIVITY; PIPERAZINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; STRESS, PSYCHOLOGICAL; SUCCINIMIDES; SWIMMING;

RATTUS;

EID: 58849120433     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.11.008     Document Type: Article

References (83)

1. Abrams J.K., Johnson P.L., Hay-Schmidt A., Mikkelsen J.D., Shekhar A., and Lowry C.A. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 133 (2005) 983-997
2. Akana S.F., Dallman M.F., Bradbury M.J., Scribner K.A., Strack A.M., and Walker C.D. Feedback and facilitation in the adrenocortical system: unmasking facilitation by partial inhibition of the glucocorticoid response to prior stress. Endocrinology 131 (1992) 57-68
3. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol 264 (1994) 259-264
4. Azmitia E.C., and McEwen B.S. Adrenalcortical influence on rat brain tryptophan hydroxylase activity. Brain Res 78 (1974) 291-302
5. 1A receptor agonist. Eur J Pharmacol 297 (1996) 205-211
6. Beer M., Kennett G.A., and Curzon G. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Eur J Pharmacol 178 (1990) 179-187
7. Bellido I., Hansson A.C., Gómez-Luque A.J., Andbjer B., Agnati L.F., and Fuxe K. Corticosterone strongly increases the affinity of dorsal raphe 5-HT1A receptors. Neuroreport 15 (2004) 1457-1459
8. Bonaventure P., Nepomuceno D., Kwok A., Chai W., Langlois X., Hen R., et al. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice. J Pharmacol Exp Ther 302 (2002) 240-248
9. Briones-Aranda A., and Picazo O. Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents. Eur J Pharmacol 508 (2005) 155-158
10. Briones-Aranda A., López-Rubalcava C., and Picazo O. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice. Psychopharmacology 162 (2002) 147-155
11. Briones-Aranda A., Rocha L., and Picazo O. Influence of forced swimming stress on 5-HT1A receptors and serotonin levels in mouse brain. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 275-281
12. Chalmers D.T., and Watson S.J. Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain: a combined in situ hybridization/in vitro receptor autoradiographic study. Brain Res 561 (1991) 51-60
13. Chalmers D.T., Kwak S.P., Mansour A., Akil H., and Watson S.J. Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. J Neurosci 13 (1993) 914-923
14. Dallman M.F., Akana S.F., Cascio C.S., Darlington D.N., Jacobson L., and Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res 43 (1987) 113-173
15. Engin E., and Treit D. The role of hippocampus in anxiety: intracerebral infusion studies. Behav Pharmacol 18 (2007) 365-374
16. Faure C., Mnie-Filali O., Scarna H., Debonnel G., and Haddjeri N. Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT. Neurosci Lett 404 (2006) 122-126
17. Fernández-Guasti A., and López-Rubalcava C. Modification of the anxiolytic action of 5-HT1A compounds by GABA-benzodiazepine agents in rats. Pharmacol Biochem Behav 60 (1998) 27-32
18. File, S.E., Behavior detection of anxiolytic action. In. Elliott, J.M., Heal, D.J., Marsden, C.A., editors. Experimental Approaches to Anxiety and Depression, John Wiley and Sons, Chichester, UK: E-Publishing Inc; 1992. p. 25-44.
19. File S.E., Gonzalez L.E., and Andrews N. Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. J Neurosci 16 (1996) 4810-4815
20. Firk C., and Markus C.R. Serotonin by stress interaction: a susceptibility factor for the development of depression?. J Psychopharmacol 21 (2007) 538-544
21. Gonzalez L.E., Andrews N., and File S.E. 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res 732 (1996) 145-153
22. Griebel G., Rodgers R.J., Perrault G., and Sanger D.J. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety. Neuropharmacology 39 (2000) 1848-1857
23. Guscott M.R., Egan E., Cook G.P., Stanton J.A., Beer M.S., Rosahl T.W., et al. The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor. Neuropharmacology 44 (2003) 1031-1037
24. Hedlund P.B., Kelly L., Mazur C., Lovenberg T., Sutcliffe J.G., and Bonaventure P. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol 487 (2004) 125-132
25. Hodges H., Green S., and Glenn B. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology 92 (1987) 491-504
26. Holmes M.C., French K.L., and Seckl J.R. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Brain Res Mol Brain Res 28 (1995) 186-192
27. Imaki T., Nahan J.L., Rivier C., Sawchenko P.E., and Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J Neurosci 11 (1991) 585-599
28. Ji G., Fu Y., Ruppert K.A., and Neugebauer V. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain 3 (2007) 13
29. Jingami H., Matsukura S., Numa S., and Imura H. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. Endocrinology 117 (1985) 1314-1320
30. Kennett G.A., Marcou M., Dourish C.T., and Curzon G. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol 138 (1987) 53-60
31. King C.M.F., Gommans J., Joordens R.J.E., Hijzen T.H., Maes R.A.A., and Olivier B. Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat. Eur J Pharmacol 325 (1997) 121-128
32. Kuhar M.J. Neuroanatomical substrates of anxiety: a brief survey. Trend Neurosci 9 (1986) 307-311
33. Kuroda Y., Watanabe Y., Albeck D.S., Hastings N.B., and McEwen B.S. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on 5-HT1A and 5-HT2 receptor binding and 5-HT transporter mRNA expression in rat brain. Brain Res 648 (1994) 157-161
34. Laaris N., Le Poul E., Laporte A.M., Hamon M., and Lanfumey L. Differential effects of stress on presynaptic and postsynaptic 5-hydroxytryptamine-1A receptors in the rat brain: an in vitro electrophysiological study. Neuroscience 91 (1999) 947-958
35. Lanfumey L., Pardon M.C., Laaris N., Joubert C., Hanoun N., Hamon M., et al. 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. Neuroreport 10 (1999) 3369-3374
36. Le Corre S., Sharp T., Young A.H., and Harrison P.J. Increase of 5-HT7 (serotonin-7) and 5-HT1A (serotonin-1A) receptor mRNA expression in rat hippocampus after adrenalectomy. Psychopharmacology 130 (1997) 368-374
37. Lopez J.F., Chalmers D.T., Little K.Y., and Watson S.J. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43 (1998) 547-573
38. Lopez J.F., Liberzon I., Vázquez D.M., Young E.A., and Watson S.J. Serotonin 1A receptor messenger RNA regulation in the hippocampus after acute stress. Biol Psychiatry 45 (1999) 934-937
39. Meijer O.C., and de Kloet E.R. Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentate gyrus. Eur J Pharmacol 266 (1994) 255-261
40. Mendelson S.D., and McEwen B.S. Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology 55 (1992) 444-450
41. Millan M.J., Brocco M., Gobert A., Schreiber R., and Dekeyne A. S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]-pyrrolidin-3y l]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol. J Pharmacol Exp Ther 288 (1999) 1002-1014
42. Miura H., Naoi M., Nakahara D., Ohta T., and Nagatsu T. Changes in monoamine levels in mouse brain elicited by forced-swimming stress, and the protective effect of a new monoamine oxidase inhibitor, RS-8359. J Neural Transm Gen Sect 94 (1993) 175-187
43. Mokrosz M.J., Chojnacka-Wójcik E., Tatarczyñska E., Klodziñska A., Filip M., Boksa J., et al. 1-(2-Methoxyphenyl)-4-(4-succinimido)butylpiperazine (MM-77): a new, potent, postsynaptic antagonist of 5-HT1A receptors. Med Chem Res 4 (1994) 161-169
44. Neumaier J.F., Sexton T.J., Hamblin M.W., and Beck S.G. Corticosteroids regulate 5-HT(1A) but not 5-HT(1B) receptor mRNA in rat hippocampus. Brain Res Mol Brain Res 82 (2000) 65-73
45. Ogren S.O., Razani H., Elvander-Tottie E., and Kehr J. The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders. Physiol Behav 92 (2007) 172-179
46. Pace T.W., and Spencer R.L. Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor. Am J Physiol Endocrinol Metab 288 (2005) E1082-1088
47. Palkovits M., Young III W.S., Kovacs K., Toth T., and Makara G.B. Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy. Neuroscience 85 (1998) 135-147
48. Paull W.K., and Gibbs F.P. The corticotropin releasing factor (CRF) neurosecretory system in intact, adrenalectomized, and adrenalectomized-dexamethasone treated rats. An immunocytochemical analysis. Histochemistry 78 (1983) 303-316
49. Pavcovich L.A., and Valentino R.J. Regulation of a putative neurotransmitter effect of corticotropin-releasing factor: effects of adrenalectomy. J Neurosci 17 (1997) 401-408
50. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academia, New York
51. Pazos A., and Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346 (1985) 205-230
52. Picazo O., López-Rubalcava C., and Fernández-Guasti A. Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action. Brain Res Bull 37 (1995) 169-175
53. Plotsky P.M., and Sawchenko P.E. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. Endocrinology 120 (1987) 1361-1369
54. Price M.L., Kirby L.G., Valentino R.J., and Lucki I. Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Psychopharmacology 162 (2002) 406-414
55. Pucadyil T.J., Kalipatnapu S., and Chattopadhyay A. The serotonin1A receptor: a representative member of the serotonin receptor family. Cell Mol Neurobiol 25 (2005) 553-580
56. Reul J., and de Kloet E. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117 (1985) 2505-2511
57. Reul J., van den Bosch F.R., and de Kloet E.R. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J Endocrinol 115 (1987) 459-467
58. Riad M., Zimmer L., Rbah L., Watkins K.C., Hamon M., and Descarries L. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci 24 (2004) 5420-5426
59. Rodriguez-Manzo G., López-Rubalcava C., and Fernández-Guasti A. Anxiolytic-like effect of ejaculation under various sexual behavior conditions in the male rat. Physiol Behav 67 (1999) 651-657
60. Romaniuk A., Koprowska M., Krotewicz M., Strzelczuk M., and Wieczorek M. Effects of 8-OHDPAT `administration into the dorsal raphe nucleus and dorsal hippocampus on fear behavior and regional brain monoamines distribution in rats. Behav Brain Res 120 (2001) 47-57
61. Sawchenko P.E., Swanson L.W., and Vale W.W. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci U S A 81 (1984) 1883-1887
62. 1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat. Eur J Pharmacol 249 (1993) 341-351
63. Seth P., Gajendiran M., and Ganguly D.K. Desensitization of spinal 5-HT1A receptors to 8-OH-DPAT: an in vivo spinal reflex study. Neuroreport 8 (1997) 2489-2493
64. Shepard J.D., and Myers D.A. Strain differences in anxiety-like behavior: association with corticotropin-releasing factor. Behav Brain Res 186 (2008) 239-245
65. Shepard J.D., Barron K.W., and Myers D.A. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 861 (2000) 288-295
66. Shepard J.D., Barron K.W., and Myers D.A. Stereotaxic localization of corticosterone to the amygdala enhances hypothalamo-pituitary-adrenal responses to behavioral stress. Brain Res 963 (2003) 203-213
67. Sprouse J., Reynolds L., Li X., Braselton J., and Schmidt A. 8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production. Neuropharmacology 46 (2004) 52-62
68. Tejani-Butt S.M., and Labow D.M. Time course of the effects of adrenalectomy and corticosterone replacement on 5-HT1A receptors and 5-HT uptake sites in the hippocampus and dorsal raphe nucleus of the rat brain: an autoradiographic analysis. Psychopharmacology 113 (1994) 481-486
69. Thomas D.R., Middlemiss D.N., Taylor S.G., Nelson P., and Brown A.M. 5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors. Br J Pharmacol 128 (1999) 158-164
70. To Z.P., Bonhaus D.W., Eglen R.M., and Jakeman L.B. Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. Br J Pharmacol 115 (1995) 107-116
71. Tokugawa J., Ravasi L., Nakayama T., Lang L., Schmidt K.C., Seidel J., et al. Distribution of the 5-HT(1A) receptor antagonist [(18)F]FPWAY in blood and brain of the rat with and without isoflurane anesthesia. Eur J Nucl Med Mol Imaging 34 (2007) 259-266
72. Totterdell S. The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions. Neurotox Res 10 (2006) 65-85
73. Treit D. Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9 (1985) 203-222
74. Treit D., Pinel J.P., and Fibiger H.C. Conditioned defensive burying: a new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav 15 (1981) 619-626
75. Treit D., Robinson A., Rotzinger S., and Pesold C. Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test. Behav Brain Res 54 (1993) 23-24
76. Tsou A.P., Kosaka A., Bach C., Zuppan P., Yee C., Tom L., et al. Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J Neurochem 63 (1994) 456-464
77. Urbá-Holmgren R., Holmgren B., Leon B.A., and Ugarte A. Age-dependent changes in serotonergic modulation of yawning in the rat. Pharmacol Biochem Behav 43 (1992) 483-486
78. Wesolowska A., Paluchowska M.H., Gołembiowska K., and Chojnacka-Wójcik E. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats. J Pharm Pharmacol 55 (2003) 533-543
79. Wesolowska A., Paluchowska M., and Chojnacka-Wójcik E. Involvement of presynaptic 5-HT(1A) and benzodiazepine receptors in the anticonflict activity of 5-HT(1A) receptor antagonists. Eur J Pharmacol 471 (2003) 27-34
80. Wesolowska A., Nikiforuk A., and Stachowicz K. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. Eur J Pharmacol 553 (2006) 185-190
81. 7, receptor gene expression in the rat hippocampus. Mol Brain Res 45 (1997) 182-186
82. Young III W.S., Mezey E., and Siegel R.E. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci Lett 70 (1986) 198-203
83. Zhong P., and Ciaranello R.D. Transcriptional regulation of hippocampal 5-HT1a receptors by corticosteroid hormones. Brain Res Mol Brain Res 29 (1995) 23-34